News Search Results
Apr 29, 2026, 07:00 ET ESG | HitGen Releases 2025 Sustainability Report
technical services, project out-licensing and product sales, the Company has forged extensive collaborations with a broad range of pharmaceutical and biotechnology companies, chemical firms, foundations, and research institutions. As of the end of 2025, it has empowered over 600 clients globally and contributed
More news about: HitGen Inc.
Apr 29, 2026, 03:47 ET Le premier nouveau médicament au monde à base de toxine botulique recombinante de type A a reçu l'autorisation de mise sur le marché en Chine : une révolution technologique lancée par Claruvis Pharmaceutical
cliniciens du monde entier. »À propos de Claruvis PharmaceuticalClaruvis Pharmaceutical Co., Ltd, une filiale de MingMed Biotechnology, est une société biopharmaceutique axée sur l'innovation qui se concentre sur la recherche, le développement, la fabrication et la commercialisation
More news about: Claruvis Pharmaceutical
Apr 29, 2026, 03:45 ET Claruvis Pharmaceutical anuncia la aprobación de su fármaco recombinante de toxina botulínica tipo A
profesionales sanitarios de todo el mundo".Acerca de Claruvis PharmaceuticalClaruvis Pharmaceutical Co., Ltd., filial de MingMed Biotechnology, es una empresa biofarmacéutica innovadora centrada en la investigación, el desarrollo, la fabricación y la comercialización de productos de toxina
More news about: Claruvis Pharmaceutical
Apr 28, 2026, 21:00 ET Insilico's Rentosertib Inhalation Solution Receives IND Clearance for the World's First AI-Driven Candidate to Enter Direct-to-Lung Clinical Study
AI-driven workflow was reported in Nature Biotechnology in March 2024. More importantly, Rentosertib achieved the world's first proof-of-concept for the efficacy of AI-driven drug discovery with
More news about: Insilico Medicine
Apr 28, 2026, 18:00 ET Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
information and a PIN allowing them to access the live call.About Nektar TherapeuticsNektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases.
More news about: Nektar Therapeutics
Apr 28, 2026, 16:30 ET Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results
Federal Reserve Board on December 31, 2025.About Zhengye Biotechnology Holding LimitedThrough Jilin Zhengye Biological Products Co., Ltd., the Company's operating entity based in Jilin, China, Zhengye Biotechnology Holding Limited focuses on the research, development, manufacturing,
More news about: Zhengye Biotechnology Holding Limited
Apr 28, 2026, 14:30 ET NeuroSense Announces Pricing of Insider-Led PIPE Financing
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced the entry into a definitive agreement with certain investors
More news about: NeuroSense
Apr 28, 2026, 13:39 ET Small Molecule API Market to Reach USD 202.53 Billion by 2036, Driven by Generic Drug Demand and Expanding Oncology Pipeline
Procurement TrendsPrimary stakeholders in the small molecule API market include:Pharmaceutical companiesBiotechnology firmsCROs and CDMOsBuyers prioritize:Cost-effective and scalable API productionStrong regulatory
More news about: Future Market Insights
Apr 28, 2026, 12:21 ET CIRM Awards AcuraStem $7.5 Million in Grant Funding to Advance AS-241 Toward a First-in-Human Trial for ALS and FTD
PASADENA, Calif., April 28, 2026 /PRNewswire/ -- AcuraStem, a biotechnology company advancing treatments for amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neurodegenerative diseases, announced
More news about: AcuraStem - Patient-Based Therapeutics
Apr 28, 2026, 11:31 ET Appian Celebrates 2026 Innovation Award Winners
improving service delivery for their global clients.Regeneron Pharmaceuticals Inc.Regeneron Pharmaceuticals, Inc., a leading biotechnology company, has developed a pioneering approach to study design and protocol evaluation by embedding generative AI within governed, end-to-end digital
More news about: Appian
Apr 28, 2026, 11:00 ET ACROBiosystems Wins CiteAb Award, Gaining Worldwide Recognition
within global innovation ecosystems.About ACROBiosystems GroupACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and healthcare industries by providing innovative products and business models.
More news about: ACROBiosystems Group; ACROBiosystems Inc.
Apr 28, 2026, 10:27 ET Verified Clinical Trials and Chubb Announce Strategic Alliance to Advance Research Subject Safety, Data Quality, and Clinical Trial Success
tailors insurance solutions for life sciences companies, with the scale, expertise, and international capabilities to support pharmaceutical and biotechnology companies ranging from emerging innovators to some of the largest in the world. Chubb clients can benefit from an additional layer of protection
More news about: Verified Clinical Trials LLC
Apr 28, 2026, 10:12 ET Verified Clinical Trials and Chubb Announce Strategic Alliance to Advance Research Subject Safety, Data Quality, and Clinical Trial Success
tailors insurance solutions for life sciences companies, with the scale, expertise, and international capabilities to support pharmaceutical and biotechnology companies ranging from emerging innovators to some of the largest in the world. Chubb clients can benefit from an additional layer of protection
More news about: Verified Clinical Trials LLC
Apr 28, 2026, 10:00 ET ACROBiosystems Showcases AI-Driven Innovation at AACR 2026, Empowering Next-Generation Biologics Discovery
logistics and dedicated technical support.About ACROBiosystems GroupACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and healthcare industries by providing innovative products and business models.
More news about: ACROBiosystems Inc.; ACROBiosystems Group
Apr 28, 2026, 09:05 ET Nuevocor Appoints Dr. Monica Shah as Chief Medical Officer
SINGAPORE, PARIS and PHILADELPHIA, April 28, 2026 /PRNewswire/ -- Nuevocor, a clinical-stage biotechnology company developing novel therapies for patients suffering from life-threatening cardiomyopathies, today announced the appointment of Monica Shah,
More news about: Nuevocor
Apr 28, 2026, 09:00 ET PicnicHealth Rebrands as PicnicAI, Building Intelligence to Accelerate Human Health
need for the market to understand who the company serves with each of its brands and how.PicnicResearch serves pharmaceutical and biotechnology sponsors who require rigorous standards of credibility, data quality, and research excellence. Built on direct patient relationships, PicnicResearch
More news about: PicnicHealth
Apr 28, 2026, 08:56 ET Goddess Maintenance Introduces Armor™ Protection Mist, a Breakthrough Pre-Chemical Treatment Redefining Hair Protection in Color and Chemical Services
prevents it at the molecular level - while enhancing the final result in terms of strength, shine, and color integrity."With its fusion of biotechnology and performance-driven results, Goddess Armor™ Protection Mist furthers Goddess Maintenance Co.'s creation of the BioProtection™ category, a protection-first
More news about: Goddess Maintenance Co.
Apr 28, 2026, 08:38 ET World's First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical
patients and clinicians worldwide."About Claruvis PharmaceuticalClaruvis Pharmaceutical Co., Ltd, a subsidiary of MingMed Biotechnology, is an innovation-driven biopharmaceutical company focused on the research, development, manufacturing, and commercialization of recombinant botulinum
More news about: Claruvis Pharmaceutical
Apr 28, 2026, 08:38 ET World's First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical
patients and clinicians worldwide."About Claruvis PharmaceuticalClaruvis Pharmaceutical Co., Ltd, a subsidiary of MingMed Biotechnology, is an innovation-driven biopharmaceutical company focused on the research, development, manufacturing, and commercialization of recombinant botulinum
More news about: Claruvis Pharmaceutical
Apr 28, 2026, 08:26 ET Penn Dental Medicine Study Investigates Plant-encapsulated Delivery Platform for Oral Delivery of GLP-1 Drugs
Plant Biotechnology Journal, show that lettuce chloroplasts can produce functional GLP-1 peptides, paving the way to more affordable and better-tolerated
More news about: PENN DENTAL MEDICINE
Apr 28, 2026, 08:05 ET Rigel Announces Conference Call and Webcast to Report First Quarter 2026 Financial Results
replay for 90 days after the call via the Rigel website.About RigelRigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders
More news about: Rigel Pharmaceuticals, Inc.
Apr 28, 2026, 08:00 ET Argo Biopharma Announces First Subject Dosed in Phase I Study of siRNA Therapeutic BW-50218
YORK, April 28, 2026 /PRNewswire/ -- Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage biotechnology company committed to developing next-generation siRNA therapies, today announced the first subject has been dosed in its Phase I clinical trial
More news about: Argo Biopharmaceutical Co., Ltd
Apr 28, 2026, 08:00 ET Trailhead Biosystems Expands iPSC Derived Cell Portfolio with TrailBio® Endothelial Cells
BEACHWOOD, Ohio, April 28, 2026 /PRNewswire/ -- Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing human cell innovation, announces the commercial launch of TrailBio® Endothelial Cells, a functionally validated iPSC-derived model
More news about: Trailhead Biosystems Inc
Apr 28, 2026, 07:37 ET Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework
commercial stages in China.Frontier technology incubation: Exploration of joint ventures or new entities to localize cutting-edge biotechnology and foster sovereign R&D capabilities in the UAE across small molecules, biologics, radiopharmaceuticals, small interfering RNA therapies, and
More news about: Fosun Pharma
Apr 28, 2026, 07:33 ET Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors
Tucker is a veteran biotechnology executive with more than two decades of leadership experience spanning public and private companies and discovery to late-stage drug development. He currently serves as Chief Executive Officer and Director of Enveric Biosciences, a biotechnology company focused on advancing
More news about: Lakewood-Amedex Biotherapeutics Inc.